BEAM-301 — Initial data
2026
Beam expects to report initial clinical data in 2026.Source filing
catalyst calendar
BEAM THERAPEUTICS INC · Data as of 2026-10-25
2026
Beam expects to report initial clinical data in 2026.Source filing
2026
In addition, Beam expects to present detailed and updated BEAM-302 data at a medical congress in 2026.Source filing
Late 2026
Beam expects to report updated data for the BEACON trial by year-end 2026 and submit a biologics license application (BLA) for risto-cel as early as year-end 2026.Source filing